Workflow
Antibiotic Resistance
icon
Search documents
Kane Biotech Announces Conversion of Demand Loan from Insider into an Unsecured Convertible Debenture and Annual General Meeting Voting Results
Globenewswire· 2025-06-26 21:05
Not for distribution to U.S. news wire services or dissemination in the United States WINNIPEG, Manitoba, June 26, 2025 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE) (the “Company” or “Kane Biotech”) announces that today it has completed its previously announced conversion (the “Transaction”) of an unsecured demand loan of $1 million from an insider of the Company into a $1 million principal amount 3% unsecured convertible debenture that is due on June 26, 2030 (the “Debenture”). For further details on ...
Iterum Therapeutics(ITRM) - 2025 Q1 - Earnings Call Transcript
2025-05-13 13:32
Iterum Therapeutics (ITRM) Q1 2025 Earnings Call May 13, 2025 08:30 AM ET Company Participants Louise Barrett - Senior Vice President of Legal Affairs & SecretaryCorey Fishman - CEOJudith Matthews - Chief Financial OfficerMatthew Keller - Equity Research Associate Operator Hello, everyone, and thank you for joining the Ichorum Therapeutics plc First Quarter twenty twenty five Earnings and Business Update Call. My name is Lucy, and I'll be coordinating your call today. I will now hand over to your host, Loui ...
Cumberland Pharmaceuticals(CPIX) - 2025 Q1 - Earnings Call Transcript
2025-05-06 21:32
Cumberland Pharmaceuticals Inc (CPIX) Q1 2025 Earnings Call May 06, 2025 04:30 PM ET Company Participants Molly Aggas - Account SupervisorA.J. Kazimi - Founder, Chairman & CEOTodd Anthony - Vice President of Organizational DevelopmentJohn Hamm - VP & CFO Operator Good afternoon, and welcome to the Cumberland Pharmaceuticals first quarter twenty twenty five financial report and company update. This call is being recorded at the company's request and will be archived on its website for one year from today's d ...
Cumberland Pharmaceuticals(CPIX) - 2024 Q4 - Earnings Call Transcript
2025-03-05 00:14
Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX) Q4 2024 Earnings Conference Call March 4, 2025 4:30 PM ET Company Participants Molly Aggas – Account Supervisor-Dalton Agency A.J. Kazimi – Chief Executive Officer Todd Anthony – Vice President-Organizational Development John Hamm – Chief Financial Officer Conference Call Participants Operator Good afternoon, and welcome to Cumberland Pharmaceuticals Fourth Quarter 2024 Financial Report and Company Update. This call is being recorded at company’s request and wil ...